You are on Trendlyne United States.
Click here
to go to India website or make
United States
as your default
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Login / Sign up
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Nektar Therapeutics
Swot
Nektar Therapeutics SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Nektar Therapeutics has 5 Strengths, 11 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(5)
Weakness
(11)
Opportunity
(0)
Threats
(3)
Others
(1)
Best results last week in YoY net profit and revenue growth
Relative Outperformance versus Industry over 1 Week
Increasing Revenue every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 2 quarters
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
Promoters increasing shareholding QoQ
